The Role of TNF-alpha in Insulin Resistance

Overview

Journal Endocrine

Specialty Endocrinology

Date 2004 May 18

PMID 15146098

Citations 143

Authors

Stephen E Borst

Affiliations

Soon will be listed here.

Abstract

Insulin resistance is an important component of the metabolic syndrome associated with obesity. Early-stage insulin-resistance and related mild glucose intolerance may be compensated by increased insulin secretion. When combined with impaired insulin secretion, insulin resistance plays an important role in type 2 diabetes (1). Insulin-resistance is also associated with a variety of pathological conditions, including trauma, infection, and cancer. Obesity and type 2 diabetes are the most common metabolic diseases in Western societies, together affecting as much as half of the adult population (2). The prevalence of these conditions is not only high, but continues to increase. We have only recently come to appreciate the role of fat, especially visceral fat, as an endocrine organ. Visceral fat is the source of a number of substances which might play a role in the development of insulin resistance. Among the latter are tumor necrosis factor-alpha (TNF-alpha), adiponectin, IL-6, resistin and free fatty acids. This review will discuss the regulation of insulin responses by TNF-alpha and evidence supporting the hypothesis that over expression of TNF-alpha plays a role in the pathophysiology of insulin resistance.

Citing Articles

Loss of RIP3 alleviates insulin resistance and inflammation in gestational diabetes mellitus mice via TLR4/MyD88/NF-κB signaling pathway.

He Y, Zhu W, Qiu Y, Zhou K BMC Pregnancy Childbirth. 2025; 25(1):163.

PMID: 39953423 PMC: 11829474. DOI: 10.1186/s12884-025-07217-8.

Near telomere-to-telomere genome assemblies of Silkie Gallus gallus and Mallard Anas platyrhynchos restored the structure of chromosomes and "missing" genes in birds.

Zhao Q, Yin Z, Hou Z J Anim Sci Biotechnol. 2025; 16(1):9.

PMID: 39828703 PMC: 11745021. DOI: 10.1186/s40104-024-01141-1.

TNFα-CXCR1/2 partners in crime in insulin resistance conditions.

Castelli V, Kacem H, Brandolini L, Giorgio C, Scenna M, Allegretti M Cell Death Discov. 2024; 10(1):486.

PMID: 39627194 PMC: 11615304. DOI: 10.1038/s41420-024-02227-5.

Immunization with the NcMYR1 gene knockout strain effectively protected C57BL/6 mice and their pups against the challenge.

Du B, Chen M, Chang L, Zhang X, Zhang X, Wang X Virulence. 2024; 15(1):2427844.

PMID: 39607301 PMC: 11610562. DOI: 10.1080/21505594.2024.2427844.

Visseral Lipectomy Improves Metabolic Syndrome Parameters and Adipokines in a Rat Model of Metabolic Syndrome Induced by Monosodium Glutamate.

Tunc-Ata M, Altunay Z, Senol H, Kucukatay V Aesthetic Plast Surg. 2024; .

PMID: 39542896 DOI: 10.1007/s00266-024-04486-0.

References

Argiles J, Alvarez B, Lopez-Soriano F . The metabolic basis of cancer cachexia. Med Res Rev. 1997; 17(5):477-98. DOI: 10.1002/(sici)1098-1128(199709)17:5<477::aid-med3>3.0.co;2-r. View

del Aguila L, Claffey K, Kirwan J . TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol. 1999; 276(5):E849-55. DOI: 10.1152/ajpendo.1999.276.5.E849. View

Stack W, Mann S, Roy A, Heath P, Sopwith M, Freeman J . Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet. 1997; 349(9051):521-4. DOI: 10.1016/s0140-6736(97)80083-9. View

Saghizadeh M, Ong J, Garvey W, Henry R, Kern P . The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest. 1996; 97(4):1111-6. PMC: 507159. DOI: 10.1172/JCI118504. View

Fan J, Char D, Bagby G, Gelato M, Lang C . Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. Am J Physiol. 1995; 269(5 Pt 2):R1204-12. DOI: 10.1152/ajpregu.1995.269.5.R1204. View

Aguirre V, Uchida T, Yenush L, Davis R, White M . The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem. 2000; 275(12):9047-54. DOI: 10.1074/jbc.275.12.9047. View

Beltowski J . Adiponectin and resistin--new hormones of white adipose tissue. Med Sci Monit. 2003; 9(2):RA55-61. View

Dohm G, Tapscott E, Pories W, Dabbs D, Flickinger E, Meelheim D . An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest. 1988; 82(2):486-94. PMC: 303538. DOI: 10.1172/JCI113622. View

Costelli P, Carbo N, Tessitore L, Bagby G, Lopez-Soriano F, Argiles J . Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest. 1993; 92(6):2783-9. PMC: 288478. DOI: 10.1172/JCI116897. View

10.

Font de Mora J, Porras A, Ahn N, Santos E . Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation. Mol Cell Biol. 1997; 17(10):6068-75. PMC: 232456. DOI: 10.1128/MCB.17.10.6068. View

11.

Begum N, Ragolia L . Effect of tumor necrosis factor-alpha on insulin action in cultured rat skeletal muscle cells. Endocrinology. 1996; 137(6):2441-6. DOI: 10.1210/endo.137.6.8641197. View

12.

Tsigos C, Kyrou I, Chala E, Tsapogas P, Stavridis J, Raptis S . Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism. 1999; 48(10):1332-5. DOI: 10.1016/s0026-0495(99)90277-9. View

13.

Engelman J, Berg A, Lewis R, Lisanti M, Scherer P . Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes. Mol Endocrinol. 2000; 14(10):1557-69. DOI: 10.1210/mend.14.10.0542. View

14.

Hotamisligil G, Peraldi P, Budavari A, Ellis R, White M, Spiegelman B . IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996; 271(5249):665-8. DOI: 10.1126/science.271.5249.665. View

15.

Borjesson A, Norlin A, Wang X, Andersson R, Folkesson H . TNF-alpha stimulates alveolar liquid clearance during intestinal ischemia-reperfusion in rats. Am J Physiol Lung Cell Mol Physiol. 2000; 278(1):L3-12. DOI: 10.1152/ajplung.2000.278.1.L3. View

16.

Van Dullemen H, van Deventer S, Hommes D, Bijl H, Jansen J, Tytgat G . Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology. 1995; 109(1):129-35. DOI: 10.1016/0016-5085(95)90277-5. View

17.

Greenberg A, McDaniel M . Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest. 2002; 32 Suppl 3:24-34. DOI: 10.1046/j.1365-2362.32.s3.4.x. View

18.

Sharma R, Anker S . Cytokines, apoptosis and cachexia: the potential for TNF antagonism. Int J Cardiol. 2002; 85(1):161-71. DOI: 10.1016/s0167-5273(02)00244-9. View

19.

Peraldi P, Spiegelman B . TNF-alpha and insulin resistance: summary and future prospects. Mol Cell Biochem. 1998; 182(1-2):169-75. View

20.

Ragolia L, Begum N . Protein phosphatase-1 and insulin action. Mol Cell Biochem. 1998; 182(1-2):49-58. View